Abbott gains US FDA approval and CE mark for UltiSynq defibrillation lead

Regulatory Approvals — Abbott gains US FDA approval and CE mark for UltiSynq defibrillation lead  Cardiac Rhythm News

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 12, 2026.

By